IRIDEX Corporation (NASDAQ: IRIX) and Biolase (NASDAQ:BIOL) are both large-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for IRIDEX Corporation and Biolase, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IRIDEX Corporation 0 0 1 0 3.00
Biolase 0 0 1 0 3.00

IRIDEX Corporation presently has a consensus price target of $13.00, indicating a potential upside of 48.91%. Biolase has a consensus price target of $2.50, indicating a potential upside of 257.14%. Given Biolase’s higher possible upside, analysts plainly believe Biolase is more favorable than IRIDEX Corporation.

Valuation & Earnings

This table compares IRIDEX Corporation and Biolase’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
IRIDEX Corporation $46.16 million 2.19 -$11.71 million ($1.71) -5.11
Biolase $51.81 million 1.03 -$15.37 million ($0.31) -2.26

IRIDEX Corporation has higher revenue, but lower earnings than Biolase. IRIDEX Corporation is trading at a lower price-to-earnings ratio than Biolase, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares IRIDEX Corporation and Biolase’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
IRIDEX Corporation -42.22% -22.65% -18.68%
Biolase -36.28% -74.51% -40.81%

Insider and Institutional Ownership

48.3% of IRIDEX Corporation shares are held by institutional investors. Comparatively, 37.4% of Biolase shares are held by institutional investors. 5.0% of IRIDEX Corporation shares are held by company insiders. Comparatively, 7.1% of Biolase shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Risk and Volatility

IRIDEX Corporation has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, Biolase has a beta of 2.45, indicating that its stock price is 145% more volatile than the S&P 500.

Summary

Biolase beats IRIDEX Corporation on 6 of the 11 factors compared between the two stocks.

IRIDEX Corporation Company Profile

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company’s ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.

Biolase Company Profile

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

Receive News & Ratings for IRIDEX Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.